Health Economics and HTA and its role in pricing and reimbursement, pipeline and in-lisencing evaluations as well as portfolio and company valuations in the biotech and pharmaceutical sector is ever increasing. While I was searching the web for various news on the topic, I actually couldn't find a blog that offers a platform of exchange among professionals in this field around the various topics - so there we go now and I hope you enjoy the information... Cheers Ulf
11.06.2007
New master programe in health economics: "International Pharmacoeconomics and Health Economics" in Idstein, Germany
A new innovative degree can be obtained from the programe of the Europa Fachhochschule Fresenius and Cardiff University...
No comments:
Post a Comment